These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 21446712)

  • 1. Why human cytochrome P450c21 is a progesterone 21-hydroxylase.
    Mizrachi D; Wang Z; Sharma KK; Gupta MK; Xu K; Dwyer CR; Auchus RJ
    Biochemistry; 2011 May; 50(19):3968-74. PubMed ID: 21446712
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Minor activities and transition state properties of the human steroid hydroxylases cytochromes P450c17 and P450c21, from reactions observed with deuterium-labeled substrates.
    Yoshimoto FK; Zhou Y; Peng HM; Stidd D; Yoshimoto JA; Sharma KK; Matthew S; Auchus RJ
    Biochemistry; 2012 Sep; 51(36):7064-77. PubMed ID: 22873692
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epoxidation activities of human cytochromes P450c17 and P450c21.
    Yoshimoto FK; Peng HM; Zhang H; Anderson SM; Auchus RJ
    Biochemistry; 2014 Dec; 53(48):7531-40. PubMed ID: 25386927
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis of halogenated pregnanes, mechanistic probes of steroid hydroxylases CYP17A1 and CYP21A2.
    Yoshimoto FK; Desilets MC; Auchus RJ
    J Steroid Biochem Mol Biol; 2012 Jan; 128(1-2):38-50. PubMed ID: 22001566
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The enantiomer of progesterone (ent-progesterone) is a competitive inhibitor of human cytochromes P450c17 and P450c21.
    Auchus RJ; Sampath Kumar A; Andrew Boswell C; Gupta MK; Bruce K; Rath NP; Covey DF
    Arch Biochem Biophys; 2003 Jan; 409(1):134-44. PubMed ID: 12464252
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interrenal steroid 21-hydroxylase in eels: primary structure, progesterone-specific activity and enhanced expression by ACTH.
    Li YY; Inoue K; Takei Y
    J Mol Endocrinol; 2003 Oct; 31(2):327-40. PubMed ID: 14519100
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CYP17A1 exhibits 17αhydroxylase/17,20-lyase activity towards 11β-hydroxyprogesterone and 11-ketoprogesterone metabolites in the C11-oxy backdoor pathway.
    van Rooyen D; Yadav R; Scott EE; Swart AC
    J Steroid Biochem Mol Biol; 2020 May; 199():105614. PubMed ID: 32007561
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular modeling of human P450c17 (17alpha-hydroxylase/17,20-lyase): insights into reaction mechanisms and effects of mutations.
    Auchus RJ; Miller WL
    Mol Endocrinol; 1999 Jul; 13(7):1169-82. PubMed ID: 10406467
    [TBL] [Abstract][Full Text] [Related]  

  • 9. How do mutations affect the structural characteristics and substrate binding of CYP21A2? An investigation by molecular dynamics simulations.
    Lin B; Zhang H; Zheng Q
    Phys Chem Chem Phys; 2020 Apr; 22(16):8870-8877. PubMed ID: 32286592
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular dynamics of substrate complexes with hamster cytochrome P450c17 (CYP17): mechanistic approach to understanding substrate binding and activities.
    Mathieu AP; LeHoux JG; Auchus RJ
    Biochim Biophys Acta; 2003 Feb; 1619(3):291-300. PubMed ID: 12573489
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Three-dimensional structure of steroid 21-hydroxylase (cytochrome P450 21A2) with two substrates reveals locations of disease-associated variants.
    Zhao B; Lei L; Kagawa N; Sundaramoorthy M; Banerjee S; Nagy LD; Guengerich FP; Waterman MR
    J Biol Chem; 2012 Mar; 287(13):10613-10622. PubMed ID: 22262854
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human Cytochrome P450 21A2, the Major Steroid 21-Hydroxylase: STRUCTURE OF THE ENZYME·PROGESTERONE SUBSTRATE COMPLEX AND RATE-LIMITING C-H BOND CLEAVAGE.
    Pallan PS; Wang C; Lei L; Yoshimoto FK; Auchus RJ; Waterman MR; Guengerich FP; Egli M
    J Biol Chem; 2015 May; 290(21):13128-43. PubMed ID: 25855791
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Corticosteroid Biosynthesis Revisited: No Direct Hydroxylation of Pregnenolone by Steroid 21-Hydroxylase.
    Loke S; Stoll A; Machalz D; Botrè F; Wolber G; Bureik M; Parr MK
    Front Endocrinol (Lausanne); 2021; 12():633785. PubMed ID: 34149610
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical and biochemical description of a novel CYP21A2 gene mutation 962_963insA using a new 3D model for the P450c21 protein.
    Janner M; Pandey AV; Mullis PE; Flück CE
    Eur J Endocrinol; 2006 Jul; 155(1):143-51. PubMed ID: 16793961
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential inhibition of CYP17A1 and CYP21A2 activities by the P450 oxidoreductase mutant A287P.
    Dhir V; Ivison HE; Krone N; Shackleton CH; Doherty AJ; Stewart PM; Arlt W
    Mol Endocrinol; 2007 Aug; 21(8):1958-68. PubMed ID: 17505056
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CYP17A1 inhibitor abiraterone, an anti-prostate cancer drug, also inhibits the 21-hydroxylase activity of CYP21A2.
    Malikova J; Brixius-Anderko S; Udhane SS; Parween S; Dick B; Bernhardt R; Pandey AV
    J Steroid Biochem Mol Biol; 2017 Nov; 174():192-200. PubMed ID: 28893623
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of fluorine substitution on substrate conversion by cytochromes P450 17A1 and 21A2.
    Vogt CD; Bart AG; Yadav R; Scott EE; Aubé J
    Org Biomol Chem; 2021 Sep; 19(35):7664-7669. PubMed ID: 34524336
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modeling and mutagenesis of the active site of human P450c17.
    Lin D; Zhang LH; Chiao E; Miller WL
    Mol Endocrinol; 1994 Mar; 8(3):392-402. PubMed ID: 8015556
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Substitution at residue 473 confers progesterone 21-hydroxylase activity to cytochrome P450 2C2.
    Ramarao M; Kemper B
    Mol Pharmacol; 1995 Sep; 48(3):417-24. PubMed ID: 7565621
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A rare CYP 21 mutation (p.E431K) induced deactivation of CYP 21A2 and resulted in congenital adrenal hyperplasia.
    Kawashima Y; Usui T; Fujimoto M; Miyahara N; Nishimura R; Hanaki K; Kanzaki S
    Endocr J; 2015; 62(1):101-6. PubMed ID: 25319875
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.